Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>With the revised Common Rule removing pregnant women from the list of &ldquo;vulnerable populations&rdquo; in 2019, it is time for IRBs to reconsider the default exclusion of expectant mothers from clinical trials, a bioethicist argued in a new paper.</p>

Pregnant Women Face ‘Default’ Exclusion From Clinical Trials

IRBs should reconsider inclusion in light of Common Rule change